Deactivation of Akt and STAT3 signaling promotes apoptosis, inhibits proliferation, and enhances the sensitivity of hepatocellular carcinoma cells to an anticancer agent, atiprimod

被引:73
作者
Choudhari, Sweeta R.
Khan, Muhammad A.
Harris, Genesis
Picker, Donald
Jacob, Gary S.
Block, Timothy
Shailubhai, Kunwar
机构
[1] Penn Biotechnol Ctr, Drexel Inst Biotechnol & Virol Res, Inst Hepatitis & Virus Res, Doylestown, PA 18902 USA
[2] Callisto Pharmaceut Inc, New York, NY USA
关键词
D O I
10.1158/1535-7163.MCT-06-0561
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Atiprimod is a novel anticancer and antiangiogenic drug candidate which is currently being evaluated in patients with liver carcinoid and multiple myeloma. In this study, we report that atiprimod selectively inhibited proliferation and induced apoptosis in HCC cells that expressed either hepatitis B virus (HBV) or hepatitis C virus, through deactivation of protein kinase B (Akt) and signal transducers and activators of transcription 3 (STAT3) signaling. In HepG2 AD38 cells, which express HBV genome under the control of a tetracycline-off promoter, both Akt and STAT3 were constitutively activated in response to HBV expression. However, this constitutive activation was not sensitive to lamivudine, a drug that inhibits HBV replication without affecting its gene expression, suggesting that HBV replication per se might not be responsible for the activation. Interestingly, the electrophoretic mobility of p-STAT3 protein bands on immunoblot was slower when AD38 cells were cultured in the absence of tetracycline, suggesting a differential phosphorylation in response to HBV expression. In HCC cells, interleukin 6 stimulates the phosphorylation of STAT3 both at serine 727 and at tyrosine 705 positions. The interleukin 6-stimulated activation of STAT3 and Akt was inhibited not only by atiprimod but also by LY294002, a phosphoinositide-3-kinase-specific inhibitor, and by NS398, a cyclooxygenase-2-selective inhibitor. The combination of these compounds did not produce any additive effect, implying that the mechanisms by which HBV activates Akt and STAT3 might also involve phosphoinositide-3-kinase and cyclooxygenase-2. Collectively, these results suggest that atiprimod could be useful as a multifunctional drug candidate for the treatment of HCC in humans.
引用
收藏
页码:112 / 121
页数:10
相关论文
共 50 条
[1]   Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha [J].
Alessi, DR ;
James, SR ;
Downes, CP ;
Holmes, AB ;
Gaffney, PRJ ;
Reese, CB ;
Cohen, P .
CURRENT BIOLOGY, 1997, 7 (04) :261-269
[2]   Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cells [J].
Amit-Vazina, M ;
Shishodia, S ;
Harris, D ;
Van, Q ;
Wang, M ;
Weber, D ;
Alexanian, R ;
Talpaz, M ;
Aggarwal, BB ;
Estrov, Z .
BRITISH JOURNAL OF CANCER, 2005, 93 (01) :70-80
[3]   The proapoptotic effect of hepatitis B virus HBx protein correlates with its transactivation activity in stably transfected cell lines [J].
Bergametti, F ;
Prigent, S ;
Luber, B ;
Benoit, A ;
Tiollais, P ;
Sarasin, A ;
Transy, C .
ONCOGENE, 1999, 18 (18) :2860-2871
[4]   Molecular mechanisms underlying the development of hepatocellular carcinoma [J].
Bergsland, EK .
SEMINARS IN ONCOLOGY, 2001, 28 (05) :521-531
[5]  
Blum HE, 2005, WORLD J GASTROENTERO, V11, P7391
[6]   Activation of focal adhesion kinase by hepatitis B virus HBx protein: Multiple functions in viral replication [J].
Bouchard, MJ ;
Wang, LH ;
Schneider, RJ .
JOURNAL OF VIROLOGY, 2006, 80 (09) :4406-4414
[7]   Activation and inhibition of cellular calcium and tyrosine kinase signaling pathways identify targets of the HBx protein involved in hepatitis B virus replication [J].
Bouchard, MJ ;
Puro, RJ ;
Wang, LH ;
Schneider, RJ .
JOURNAL OF VIROLOGY, 2003, 77 (14) :7713-7719
[8]  
BRAITEH FS, 2006, P ASCO ANN M JUN 2 6
[9]  
Chandler PR, 2002, APPL OPTIMIZAT, V66, P1
[10]   STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation [J].
Chung, JK ;
Uchida, E ;
Grammer, TC ;
Blenis, J .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (11) :6508-6516